These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32831157)

  • 1. Analysis of the inflammatory tumor microenvironment in meningeal neoplasms.
    Berghoff AS; Kresl P; Rajky O; Widhalm G; Ricken G; Hainfellner JA; Marosi C; Birner P; Preusser M
    Clin Neuropathol; 2020; 39(6):256-262. PubMed ID: 32831157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between programmed cell death ligand-1 expression and extracranial metastasis in intracranial solitary fibrous tumor/hemangiopericytoma.
    Kamamoto D; Ohara K; Kitamura Y; Yoshida K; Kawakami Y; Sasaki H
    J Neurooncol; 2018 Sep; 139(2):251-259. PubMed ID: 29675794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC).
    Berghoff AS; Ricken G; Wilhelm D; Rajky O; Widhalm G; Dieckmann K; Birner P; Bartsch R; Preusser M
    J Neurooncol; 2016 Oct; 130(1):19-29. PubMed ID: 27436101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour infiltrating lymphocyte density differs by meningioma type and is associated with prognosis in atypical meningioma.
    Turner CP; McLay J; Hermans IF; Correia J; Bok A; Mehrabi N; Gock S; Highet B; Curtis MA; Dragunow M
    Pathology; 2022 Jun; 54(4):417-424. PubMed ID: 35082053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and local immunosuppression in patients with high-grade meningiomas.
    Li YD; Veliceasa D; Lamano JB; Lamano JB; Kaur G; Biyashev D; Horbinski CM; Kruser TJ; Bloch O
    Cancer Immunol Immunother; 2019 Jun; 68(6):999-1009. PubMed ID: 31030234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas.
    Rapp C; Dettling S; Liu F; Ull AT; Warta R; Jungk C; Roesch S; Mock A; Sahm F; Schmidt M; Jungwirth G; Zweckberger K; Lamszus K; Gousias K; Kessler AF; Grabe N; Loehr M; Ketter R; Urbschat S; Senft C; Westphal M; Abdollahi A; Debus J; von Deimling A; Unterberg A; Simon M; Herold-Mende CC
    Clin Cancer Res; 2019 Sep; 25(17):5260-5270. PubMed ID: 31227506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of nuclear STAT6 immunostaining as a diagnostic marker of meningeal solitary fibrous tumor (SFT)/hemangiopericytoma.
    Berghoff AS; Kresl P; Bienkowski M; Koelsche C; Rajky U; Hainfellner JA; Preusser M
    Clin Neuropathol; 2017; 36 (2017)(2):56-59. PubMed ID: 28128724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma.
    Du Z; Abedalthagafi M; Aizer AA; McHenry AR; Sun HH; Bray MA; Viramontes O; Machaidze R; Brastianos PK; Reardon DA; Dunn IF; Freeman GJ; Ligon KL; Carpenter AE; Alexander BM; Agar NY; Rodig SJ; Bradshaw EM; Santagata S
    Oncotarget; 2015 Mar; 6(7):4704-16. PubMed ID: 25609200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A collision tumor of solitary fibrous tumor/hemangiopericytoma and meningioma: A case report with literature review.
    Ashizawa K; Ogura K; Nagase S; Sakaguchi A; Tokugawa J; Hishii M; Fukunaga M; Hirose T; Matsumoto T
    Pathol Int; 2021 Oct; 71(10):697-706. PubMed ID: 34411369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between tumor microenvironment and clinicopathological parameters in meningioma.
    Ding Y; Qiu L; Xu Q; Song L; Yang S; Yang T
    Int J Clin Exp Pathol; 2014; 7(10):6973-9. PubMed ID: 25400783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of thyroid transcription factor-1 in meningeal solitary fibrous tumor/hemangiopericytoma.
    Wu H; Du J; Li H; Li Y; Zhang W; Zhou W; Wang W
    Brain Tumor Pathol; 2021 Apr; 38(2):122-131. PubMed ID: 33666786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Diagnosis of Meningeal SFT-HPC and Meningioma: Which Immunohistochemical Markers Should Be Used?
    Macagno N; Figarella-Branger D; Mokthari K; Metellus P; Jouvet A; Vasiljevic A; Loundou A; Bouvier C
    Am J Surg Pathol; 2016 Feb; 40(2):270-8. PubMed ID: 26448189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Radiographic Features for Differentiating Solitary Fibrous Tumor/Hemangiopericytoma From Meningioma.
    Ohba S; Murayama K; Nishiyama Y; Adachi K; Yamada S; Abe M; Hasegawa M; Hirose Y
    World Neurosurg; 2019 Oct; 130():e383-e392. PubMed ID: 31233926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast.
    Kim M; Chung YR; Kim HJ; Woo JW; Ahn S; Park SY
    Breast Cancer Res; 2020 Mar; 22(1):32. PubMed ID: 32216826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-tumor histogram analysis of apparent diffusion coefficient in differentiating intracranial solitary fibrous tumor/hemangiopericytoma from angiomatous meningioma.
    He W; Xiao X; Li X; Guo Y; Guo L; Liu X; Xu Y; Zhou J; Wu Y
    Eur J Radiol; 2019 Mar; 112():186-191. PubMed ID: 30777209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.
    Han SJ; Reis G; Kohanbash G; Shrivastav S; Magill ST; Molinaro AM; McDermott MW; Theodosopoulos PV; Aghi MK; Berger MS; Butowski NA; Barani I; Phillips JJ; Perry A; Okada H
    J Neurooncol; 2016 Dec; 130(3):543-552. PubMed ID: 27624915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy.
    Dieci MV; Tsvetkova V; Griguolo G; Miglietta F; Tasca G; Giorgi CA; Cumerlato E; Massa D; Lo Mele M; Orvieto E; Guarneri V; Conte P
    Eur J Cancer; 2020 Sep; 136():7-15. PubMed ID: 32622323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer.
    Sugie T; Sato E; Miyashita M; Yamaguchi R; Sakatani T; Kozuka Y; Moritani S; Suzuki E; Kakimi K; Mikami Y; Moriya T
    Breast Cancer; 2020 Jul; 27(4):519-526. PubMed ID: 32447649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas.
    Yeung J; Yaghoobi V; Aung TN; Vesely MD; Zhang T; Gaule P; Gunel M; Rimm DL; Chen L
    J Neuropathol Exp Neurol; 2021 Jan; 80(2):150-159. PubMed ID: 33393633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1/PD-L1 expression in a series of intracranial germinoma and its association with Foxp3+ and CD8+ infiltrating lymphocytes.
    Liu B; Arakawa Y; Yokogawa R; Tokunaga S; Terada Y; Murata D; Matsui Y; Fujimoto KI; Fukui N; Tanji M; Mineharu Y; Minamiguchi S; Miyamoto S
    PLoS One; 2018; 13(4):e0194594. PubMed ID: 29617441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.